首页 > 最新文献

Principles and practice of clinical research (2015)最新文献

英文 中文
Neuromuscular Electrical Stimulation (NMES) as an Add-on Therapy for the Improvement of Dyspnea in Patients with Post-Covid Syndrome: a Protocol for a Phase II Randomized, Non-Pharmacological Intervention-Controlled, Double-Blind Study. 神经肌肉电刺激(NMES)作为改善新冠肺炎后综合征患者呼吸困难的附加疗法:一项随机、非药物干预对照、双盲研究方案
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.1
Anusree Anil Kumar
{"title":"Neuromuscular Electrical Stimulation (NMES) as an Add-on Therapy for the Improvement of Dyspnea in Patients with Post-Covid Syndrome: a Protocol for a Phase II Randomized, Non-Pharmacological Intervention-Controlled, Double-Blind Study.","authors":"Anusree Anil Kumar","doi":"10.21801/ppcrj.2022.83.1","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.1","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41536297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Cannabidiol Versus Ibuprofen in the Relief of Menstrual Pain in Females Living with Primary Dysmenorrhea A phase II, Non-Inferiority trial 大麻二酚与布洛芬缓解女性原发性痛经疼痛的疗效:II期非劣效性试验
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.7
Haneesha Mohan
Introduction: Pain is the cardinal symptom in women living with primary dysmenorrhea (PDM), resulting in a relentless negative effect on their quality of life. Women with PDM have higher levels of prostaglandin in their endometrial fluid, which correlates with the degree of pain. The standard of care treatment for pain associated with PDM starts with nonsteroidal anti-inflammatory drugs (NSAIDs) that block prostaglandin-triggering enzymes. Although NSAIDs are a feasible option, they are also associated with a significant risk of side effects. Around 20 to 25% of patients will experience pain refractory to NSAIDs and seek alternative therapies. Cannabidiol (CBD) is a well-tolerated potential therapy for several chronic diseases, including pain, and acts by blocking prostaglandin-triggering enzymes, similar to NSAIDs. The safety of CBD is well established, with the advantage of acting via central and peripheral mechanisms. To date, no previous trials assessing CBD alone for dysmenorrhea have been conducted. Objective: To evaluate the effect of CBD alone in reducing acute menstrual pain compared to ibuprofen, as assessed by the total pain relief (TOTPAR) scale. Design: Randomized (with random block sizes), triple-blinded, multicenter, parallel-group, non-inferiority clinical trial. Participants: PDM patients aged 18 to 40 years, with regular menstrual cycles (ranging from 21 to 35 days) and a visual analog scale (VAS) score of ≥ 5. Academic Editor: Felipe Fregni Peer-reviewers: Natalia Suarez; Giovani Farina; Magali Andrea Pestana; Luis Morales Ojeda. Copyright: © 2022 by the authors. Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
简介:疼痛是原发性痛经(PDM)女性的主要症状,对她们的生活质量产生了无情的负面影响。患有PDM的女性子宫内膜液中前列腺素水平较高,这与疼痛程度有关。PDM相关疼痛的标准治疗开始于非甾体抗炎药(NSAIDs),阻断前列腺素触发酶。尽管非甾体抗炎药是一种可行的选择,但它们也有显著的副作用风险。大约20%到25%的患者会对非甾体抗炎药产生难治性疼痛,并寻求替代疗法。大麻二酚(CBD)是一种耐受性良好的潜在治疗多种慢性疾病,包括疼痛,并通过阻断前列腺素触发酶起作用,类似于非甾体抗炎药。CBD的安全性是公认的,具有通过中枢和外周机制起作用的优势。迄今为止,还没有单独评估CBD治疗痛经的试验。目的:通过总疼痛缓解(TOTPAR)量表评估CBD与布洛芬在减轻急性经期疼痛方面的效果。设计:随机(随机分组大小)、三盲、多中心、平行组、非劣效性临床试验。参与者:年龄18 - 40岁,月经周期正常(21 - 35天),视觉模拟评分(VAS)评分≥5的PDM患者。学术编辑:Felipe Fregni同行评审:Natalia Suarez;Giovani淀粉;Magali Andrea Pestana;路易斯·莫拉莱斯·奥赫达。版权所有:©2022作者所有。知识共享署名(CC BY)许可(https://creativecommons.org/licenses/by/4.0/)。
{"title":"Efficacy of Cannabidiol Versus Ibuprofen in the Relief of Menstrual Pain in Females Living with Primary Dysmenorrhea A phase II, Non-Inferiority trial","authors":"Haneesha Mohan","doi":"10.21801/ppcrj.2022.83.7","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.7","url":null,"abstract":"Introduction: Pain is the cardinal symptom in women living with primary dysmenorrhea (PDM), resulting in a relentless negative effect on their quality of life. Women with PDM have higher levels of prostaglandin in their endometrial fluid, which correlates with the degree of pain. The standard of care treatment for pain associated with PDM starts with nonsteroidal anti-inflammatory drugs (NSAIDs) that block prostaglandin-triggering enzymes. Although NSAIDs are a feasible option, they are also associated with a significant risk of side effects. Around 20 to 25% of patients will experience pain refractory to NSAIDs and seek alternative therapies. Cannabidiol (CBD) is a well-tolerated potential therapy for several chronic diseases, including pain, and acts by blocking prostaglandin-triggering enzymes, similar to NSAIDs. The safety of CBD is well established, with the advantage of acting via central and peripheral mechanisms. To date, no previous trials assessing CBD alone for dysmenorrhea have been conducted. Objective: To evaluate the effect of CBD alone in reducing acute menstrual pain compared to ibuprofen, as assessed by the total pain relief (TOTPAR) scale. Design: Randomized (with random block sizes), triple-blinded, multicenter, parallel-group, non-inferiority clinical trial. Participants: PDM patients aged 18 to 40 years, with regular menstrual cycles (ranging from 21 to 35 days) and a visual analog scale (VAS) score of ≥ 5. Academic Editor: Felipe Fregni Peer-reviewers: Natalia Suarez; Giovani Farina; Magali Andrea Pestana; Luis Morales Ojeda. Copyright: © 2022 by the authors. Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48093128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and hemodynamic phenotype of BMPR2 variation carriers with pulmonary arterial hypertension: A systematic review and a call to action 肺动脉高压BMPR2变异携带者的临床和血流动力学表型:系统回顾和行动呼吁
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.9
David Rodríguez, Miguel A. Floran-Bautista, B. Illigens, Tiago Lemos Cerqueira, A. Ramírez-Rivera, C. Jerjes-Sánchez
{"title":"Clinical and hemodynamic phenotype of BMPR2 variation carriers with pulmonary arterial hypertension: A systematic review and a call to action","authors":"David Rodríguez, Miguel A. Floran-Bautista, B. Illigens, Tiago Lemos Cerqueira, A. Ramírez-Rivera, C. Jerjes-Sánchez","doi":"10.21801/ppcrj.2022.83.9","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.9","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42825400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of over-the-scope clips® com-pared to through-the-scope clips for initial bleeding control in non-variceal upper gastrointestinal bleeding: a multicenter randomized clinical trial 非静脉曲张性上消化道出血患者经内镜夹与经内镜夹治疗初期出血的疗效和安全性:一项多中心随机临床试验
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.3
F. Lopes
:
{"title":"Efficacy and safety of over-the-scope clips® com-pared to through-the-scope clips for initial bleeding control in non-variceal upper gastrointestinal bleeding: a multicenter randomized clinical trial","authors":"F. Lopes","doi":"10.21801/ppcrj.2022.83.3","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.3","url":null,"abstract":":","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48986672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective Effect of Surgical Masks versus N95 Respirator in Prevention of SARS-CoV-2 Contami-nation in Healthcare Professionals: Systematic Re-view Protocol 医用口罩与N95口罩对医护人员预防SARS-CoV-2污染的防护效果:系统评价方案
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.4
R. L. Gonçalves
: Introduction
:简介
{"title":"Protective Effect of Surgical Masks versus N95 Respirator in Prevention of SARS-CoV-2 Contami-nation in Healthcare Professionals: Systematic Re-view Protocol","authors":"R. L. Gonçalves","doi":"10.21801/ppcrj.2022.83.4","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.4","url":null,"abstract":": Introduction","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44130533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The KDEP Trial: Protocol for a phase II, multicenter, open label, randomized controlled trial to evaluate the efficacy of ketogenic diet for symptomatic improvement of moderate to severe Major Depressive Disorder KDEP试验:一项II期、多中心、开放标签、随机对照试验的方案,旨在评估生酮饮食对中重度重度抑郁症症状改善的疗效
Pub Date : 2022-12-20 DOI: 10.21801/ppcrj.2022.83.10
Gargi Kakani
{"title":"The KDEP Trial: Protocol for a phase II, multicenter, open label, randomized controlled trial to evaluate the efficacy of ketogenic diet for symptomatic improvement of moderate to severe Major Depressive Disorder","authors":"Gargi Kakani","doi":"10.21801/ppcrj.2022.83.10","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.10","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43787877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Bench to Bedside - the translation of intracortical inhibition marker to clinical practice. 编辑:从实验室到床边——皮质内抑制标志物到临床实践的转化。
Pub Date : 2022-12-02 DOI: 10.21801/ppcrj.2022.83.11
Danielle Carolina Pimenta, Daniel Lima, Eric Slawka, Kevin Pacheco-Barrios, Felipe Fregni
{"title":"Editorial: Bench to Bedside - the translation of intracortical inhibition marker to clinical practice.","authors":"Danielle Carolina Pimenta, Daniel Lima, Eric Slawka, Kevin Pacheco-Barrios, Felipe Fregni","doi":"10.21801/ppcrj.2022.83.11","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.83.11","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10343941/pdf/nihms-1863078.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9823803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telehealth usability evaluation by healthcare professionals in post-pandemic treatment of non-communicable diseases (hypertension and diabetes): Systematic Review Protocol 卫生保健专业人员在大流行后非传染性疾病(高血压和糖尿病)治疗中的远程保健可用性评价:系统审查议定书
Pub Date : 2022-11-28 DOI: 10.21801/ppcrj.2022.82.6
R. L. Gonçalves, A. Pagano, Z. Reis, Seth Kwaku Afagbedzi, Michael Head, K. Brackstone, M. Marcolino, T. Lopes, S. A. Cordeiro, J. M. Nunes, James Batchelor, A. L. P. Ribeiro
{"title":"Telehealth usability evaluation by healthcare professionals in post-pandemic treatment of non-communicable diseases (hypertension and diabetes): Systematic Review Protocol","authors":"R. L. Gonçalves, A. Pagano, Z. Reis, Seth Kwaku Afagbedzi, Michael Head, K. Brackstone, M. Marcolino, T. Lopes, S. A. Cordeiro, J. M. Nunes, James Batchelor, A. L. P. Ribeiro","doi":"10.21801/ppcrj.2022.82.6","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.82.6","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42350326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurofeedback for Attention Deficit Disorder in preschoolers (NeFAP): A randomized, sham-controlled, efficacy study protocol of a novel non-pharmacological therapy 学龄前儿童注意缺陷障碍的神经反馈(NeFAP):一种新的非药物治疗的随机、假对照、疗效研究方案
Pub Date : 2022-11-28 DOI: 10.21801/ppcrj.2022.82.7
A. Pugliesi, Niraj A. Mehta, Daniel Guimarães Silva, Jennifer P. Khouri López, Cornelis Anibal Luna Fuerte, Nicolas Nuñez-Ordonez, Suzy Krimon, Omar Kotb, Sahilly Adelina Rodríguez-Martínez, Janaina Lima, Douaa Omer Mohamed, Cristiane Paulain David, Nathalia Satoo Demian F., Joyce Macedo da Silva, A. Yock-Corrales
{"title":"Neurofeedback for Attention Deficit Disorder in preschoolers (NeFAP): A randomized, sham-controlled, efficacy study protocol of a novel non-pharmacological therapy","authors":"A. Pugliesi, Niraj A. Mehta, Daniel Guimarães Silva, Jennifer P. Khouri López, Cornelis Anibal Luna Fuerte, Nicolas Nuñez-Ordonez, Suzy Krimon, Omar Kotb, Sahilly Adelina Rodríguez-Martínez, Janaina Lima, Douaa Omer Mohamed, Cristiane Paulain David, Nathalia Satoo Demian F., Joyce Macedo da Silva, A. Yock-Corrales","doi":"10.21801/ppcrj.2022.82.7","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.82.7","url":null,"abstract":"","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46656977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness Analysis to Inform Randomized Controlled Trial Design in Chronic Pain Research: Methods for Guiding Decisions on the Addition of a Run-In Period. 慢性疼痛研究中随机对照试验设计的成本效益分析:增加磨合期的指导决策方法。
Pub Date : 2022-07-03 DOI: 10.21801/ppcrj.2022.82.5
Haley Rafferty, Elisa Rocha, Paola Gonzalez-Mego, Clara L Ramos, Mirret M El-Hagrassy, Muhammed E Gunduz, Elif Uygur-Kucukseymen, Hanan Zehry, Swapnali S Chaudhari, Paulo Ep Teixeira, Gleysson R Rosa, Ana L Zaninotto, Christopher Connor, Uri Eden, Ciro Ramos-Estebanez, Felipe Fregni, Laura Dipietro, Timothy Wagner

Introduction: Run-In (RI) periods can be used to improve the validity of randomized controlled trials (RCTs), but their utility in Chronic Pain (CP) RCTs is debated. Cost-effectiveness analysis (CEA) methods are commonly used in evaluating the results of RCTs, but they are seldom used for designing RCTs. We present a step-by-step overview to objectively design RCTs via CEA methods and specifically determine the cost effectiveness of a RI period in a CP RCT.

Methods: We applied the CEA methodology to data obtained from several noninvasive brain stimulation CP RCTs, specifically focusing on (1) defining the CEA research question, (2) identifying RCT phases and cost ingredients, (3) discounting, (4) modeling the stochastic nature of the RCT, and (5) performing sensitivity analyses. We assessed the average cost-effectiveness ratios and incremental cost effectiveness ratios of varied RCT designs and the impact on cost-effectiveness by the inclusion of a RI period vs. No-Run-In (NRI) period.

Results: We demonstrated the potential impact of varying the number of institutions, number of patients that could be accommodated per institution, cost and effectiveness discounts, RCT component costs, and patient adherence characteristics on varied RI and NRI RCT designs. In the specific CP RCT designs that we analyzed, we demonstrated that lower patient adherence, lower baseline assessment costs, and higher treatment costs all necessitated the inclusion of an RI period to be cost-effective compared to NRI RCT designs.

Conclusions: Clinical trialists can optimize CP RCT study designs and make informed decisions regarding RI period inclusion/exclusion via CEA methods.

导读:磨合期(RI)可用于提高随机对照试验(rct)的有效性,但其在慢性疼痛(CP) rct中的应用仍存在争议。成本-效果分析(CEA)方法是评价随机对照试验结果的常用方法,但很少用于随机对照试验的设计。我们通过CEA方法逐步概述客观设计RCT,并具体确定CP RCT中RI期的成本效益。方法:我们将CEA方法应用于从几个无创脑刺激CP随机对照试验中获得的数据,特别关注(1)定义CEA研究问题,(2)确定RCT阶段和成本成分,(3)贴现,(4)模拟RCT的随机性质,(5)进行敏感性分析。我们评估了不同RCT设计的平均成本-效果比和增量成本-效果比,以及纳入RI期和非磨合期(NRI)对成本-效果的影响。结果:我们展示了不同机构数量、每个机构可容纳的患者数量、成本和有效性折扣、RCT组件成本和患者依从性特征对不同RI和NRI RCT设计的潜在影响。在我们分析的特定CP RCT设计中,我们证明,与NRI RCT设计相比,较低的患者依从性、较低的基线评估成本和较高的治疗成本都需要纳入RI期以达到成本效益。结论:临床试验人员可以优化CP RCT研究设计,并通过CEA方法对RI期的纳入/排除做出明智的决定。
{"title":"Cost-Effectiveness Analysis to Inform Randomized Controlled Trial Design in Chronic Pain Research: Methods for Guiding Decisions on the Addition of a Run-In Period.","authors":"Haley Rafferty,&nbsp;Elisa Rocha,&nbsp;Paola Gonzalez-Mego,&nbsp;Clara L Ramos,&nbsp;Mirret M El-Hagrassy,&nbsp;Muhammed E Gunduz,&nbsp;Elif Uygur-Kucukseymen,&nbsp;Hanan Zehry,&nbsp;Swapnali S Chaudhari,&nbsp;Paulo Ep Teixeira,&nbsp;Gleysson R Rosa,&nbsp;Ana L Zaninotto,&nbsp;Christopher Connor,&nbsp;Uri Eden,&nbsp;Ciro Ramos-Estebanez,&nbsp;Felipe Fregni,&nbsp;Laura Dipietro,&nbsp;Timothy Wagner","doi":"10.21801/ppcrj.2022.82.5","DOIUrl":"https://doi.org/10.21801/ppcrj.2022.82.5","url":null,"abstract":"<p><strong>Introduction: </strong>Run-In (RI) periods can be used to improve the validity of randomized controlled trials (RCTs), but their utility in Chronic Pain (CP) RCTs is debated. Cost-effectiveness analysis (CEA) methods are commonly used in evaluating the results of RCTs, but they are seldom used for designing RCTs. We present a step-by-step overview to objectively design RCTs via CEA methods and specifically determine the cost effectiveness of a RI period in a CP RCT.</p><p><strong>Methods: </strong>We applied the CEA methodology to data obtained from several noninvasive brain stimulation CP RCTs, specifically focusing on (1) defining the CEA research question, (2) identifying RCT phases and cost ingredients, (3) discounting, (4) modeling the stochastic nature of the RCT, and (5) performing sensitivity analyses. We assessed the average cost-effectiveness ratios and incremental cost effectiveness ratios of varied RCT designs and the impact on cost-effectiveness by the inclusion of a RI period vs. No-Run-In (NRI) period.</p><p><strong>Results: </strong>We demonstrated the potential impact of varying the number of institutions, number of patients that could be accommodated per institution, cost and effectiveness discounts, RCT component costs, and patient adherence characteristics on varied RI and NRI RCT designs. In the specific CP RCT designs that we analyzed, we demonstrated that lower patient adherence, lower baseline assessment costs, and higher treatment costs all necessitated the inclusion of an RI period to be cost-effective compared to NRI RCT designs.</p><p><strong>Conclusions: </strong>Clinical trialists can optimize CP RCT study designs and make informed decisions regarding RI period inclusion/exclusion via CEA methods.</p>","PeriodicalId":74496,"journal":{"name":"Principles and practice of clinical research (2015)","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769699/pdf/nihms-1831819.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Principles and practice of clinical research (2015)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1